224 related articles for article (PubMed ID: 24060173)
21. Alpha/beta ratio for arteriovenous malformations estimated from obliteration rates after fractionated and single-dose irradiation.
Kocher M; Wilms M; Makoski HB; Hassler W; Maarouf M; Treuer H; Voges J; Sturm V; Müller RP
Radiother Oncol; 2004 Apr; 71(1):109-14. PubMed ID: 15066303
[TBL] [Abstract][Full Text] [Related]
22. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
23. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
Unkel S; Belka C; Lauber K
Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
[TBL] [Abstract][Full Text] [Related]
24. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population.
Marples B; Joiner MC
Radiat Res; 1993 Jan; 133(1):41-51. PubMed ID: 8434112
[TBL] [Abstract][Full Text] [Related]
25. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
[TBL] [Abstract][Full Text] [Related]
26. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.
Brenner DJ
Semin Radiat Oncol; 2008 Oct; 18(4):234-9. PubMed ID: 18725109
[TBL] [Abstract][Full Text] [Related]
27. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.
Astrahan M
Med Phys; 2008 Sep; 35(9):4161-72. PubMed ID: 18841869
[TBL] [Abstract][Full Text] [Related]
28. The application of the linear quadratic model to compensate the effects of prolonged fraction delivery time on a Balb/C breast adenocarcinoma tumor: An in vivo study.
Nikzad S; Hashemi B; Hasan ZS; Mozdarani H; Baradaran-Ghahfarokhi M; Amini P
Int J Radiat Biol; 2016; 92(2):80-6. PubMed ID: 26630280
[TBL] [Abstract][Full Text] [Related]
29. Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line.
Hermens AF; Bentvelzen PA
Cancer Res; 1992 Jun; 52(11):3073-82. PubMed ID: 1591720
[TBL] [Abstract][Full Text] [Related]
30. Dose-survival curves, alpha/beta ratios, RBE values, and equal effect per fraction for neutron irradiation of jejunal crypt cells.
Withers HR; Mason KA; Taylor JM; Kim DK; Smathers JB
Radiat Res; 1993 Jun; 134(3):295-300. PubMed ID: 8316621
[TBL] [Abstract][Full Text] [Related]
31. Modification by cis-diamminedichloroplatinum (II) of the radiation dose-response curve for intestinal crypt cells in mice.
Dewit L; Oussoren Y; Hart G
Radiat Res; 1987 Sep; 111(3):445-56. PubMed ID: 3659279
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
Chan MKH; Chiang CL
Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
[TBL] [Abstract][Full Text] [Related]
33. NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Wennberg BM; Baumann P; Gagliardi G; Nyman J; Drugge N; Hoyer M; Traberg A; Nilsson K; Morhed E; Ekberg L; Wittgren L; Lund JÅ; Levin N; Sederholm C; Lewensohn R; Lax I
Acta Oncol; 2011 May; 50(4):518-27. PubMed ID: 21198416
[TBL] [Abstract][Full Text] [Related]
34. Lack of evidence for increased tolerance of rat spinal cord with decreasing fraction doses below 2 Gy.
Ang KK; van der Kogel AJ; van der Schueren E
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):105-10. PubMed ID: 3967980
[TBL] [Abstract][Full Text] [Related]
35. A challenge to traditional radiation oncology.
Fowler JF; Tomé WA; Fenwick JD; Mehta MP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1241-56. PubMed ID: 15519797
[TBL] [Abstract][Full Text] [Related]
36. Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses.
Iwata H; Matsufuji N; Toshito T; Akagi T; Otsuka S; Shibamoto Y
J Radiat Res; 2013 Mar; 54(2):367-73. PubMed ID: 23077237
[TBL] [Abstract][Full Text] [Related]
37. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
Zhang H; Zhong H; Barth RF; Cao M; Das IJ
Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
[TBL] [Abstract][Full Text] [Related]
38. Comparison of fractionation schedules in the large heterogeneity limit.
Guerrero M
Med Phys; 2009 Apr; 36(4):1384-8. PubMed ID: 19472645
[TBL] [Abstract][Full Text] [Related]
39. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
Shibamoto Y; Otsuka S; Iwata H; Sugie C; Ogino H; Tomita N
J Radiat Res; 2012; 53(1):1-9. PubMed ID: 21997195
[TBL] [Abstract][Full Text] [Related]
40. Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study.
Miyakawa A; Shibamoto Y; Otsuka S; Iwata H
J Radiat Res; 2014 May; 55(3):451-4. PubMed ID: 24351457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
